PROTECT-Kidney Randomised Controlled Trial: MRI Pilot Study
PROTECT-Kidney Randomised Controlled Trial: MRI Pilot Study
The PROTECT-Kidney trial was designed to address the important clinical issue of contrast-induced acute kidney injury (CI-AKI), which was shown to be associated with higher mortality in patients after percutaneous coronary intervention (PCI).1 CI-AKI ranks second among all causes of acute kidney injury (AKI) and contributes to inappropriately low rates of coronary angiography in patients with chronic kidney disease....
Source: Radcliffe Cardiology - Category: Cardiology Authors: dbarot525787 Source Type: research
More News: Angiography | Angioplasty | Cardiology | Chronic Kidney Disease | Coronary Angioplasty | Heart | Percutaneous Coronary Intervention | Study | Urology & Nephrology